| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |